Hercules Capital Inc. (0J4M)
London Exchange · UK · prices in USD · close of 19 Oct 2026
Key indicators
| Last close | USD 16.02 |
|---|---|
| 52-week range | 13.35 – 18.13 |
| Return, 1 month / 3 months | −10.3% / +1.3% |
| Return, 1 year / 3 years | +1.4% / +21.4% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 33 |
| Volatility (1 year) | 24.4% |
| Worst drawdown (1 year) | -25.9% |
| Average daily value traded | 0.18M USD |
| Dividend yield | 7.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Hercules Capital is a specialty finance company based in California that provides debt and growth financing to venture-backed companies. It focuses on technology, life sciences and sustainable energy businesses, offering term loans, equipment financing and other credit facilities to firms at different stages of development. Its customers are mainly private, venture-backed companies and their investors, who use the capital to fund growth without giving up more ownership.
Hercules Capital Inc. trades under the code 0J4M on the London Exchange in UK, with its price quoted in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Hercules Capital Inc. (0J4M) trades on the London Exchange in UK. It last closed at USD 16.02 on 19 October 2026.
Its price-based Market X-Ray is 62 out of 100 (a fair price profile), ranking 1,163 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 1.4% and over the last three months it rose 1.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 63 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 0.7% | ||
| From 52-week high | -11.1% | ||
| Momentum | 61 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 1.3% | ||
| 6-month return | 5.5% | ||
| 12-month return, skipping the last month | 13.1% | ||
| Stability (higher is calmer) | 67 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 24.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -25.9% | ||
| Liquidity | 36 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.18M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 90 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 7.9% | ||
| Years with dividends | 6 |
Strengths
- Income: Dividend is high and has been paid regularly.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −3.5% |
|---|---|
| 1 month | −10.3% |
| 3 months | +1.3% |
| 6 months | +5.5% |
| 1 year | +1.4% |
| 3 years | +21.4% |
| 5 years | – |
Signals
| 50-day / 200-day average | 17.06 / 15.90 |
|---|---|
| Golden / death cross (60 days) | Golden, 36 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.50 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 11 Aug 2026 | USD 0.4000 |
| 14 May 2026 | USD 0.0700 |
| 25 Feb 2026 | USD 0.4000 |
| 12 Nov 2025 | USD 0.4000 |
| 12 Aug 2025 | USD 0.4000 |
| 13 May 2025 | USD 0.0700 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.